<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumor</z:e>-infiltrating lymphocytes (TILs) are considered to play an important role in the antitumoral immune response </plain></SENT>
<SENT sid="1" pm="."><plain>The presence and percentage of CD8-positive <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-infiltrating T cells have been shown to correlate with differentiation and prognosis in various <z:hpo ids='HP_0002664'>neoplasms</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of this study was to determine the number of CD8-positive T cells in various primary cutaneous B-cell <z:hpo ids='HP_0005523'>lymphoproliferative disorders</z:hpo> and to evaluate its correlation with the histological type of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Fifty-three lesions were examined by immunohistochemistry with antibodies targeting CD3, CD4, CD8 and <z:hpo ids='HP_0002326'>TIA</z:hpo>-1 </plain></SENT>
<SENT sid="4" pm="."><plain>Thirty-two lesions had been diagnosed as primary cutaneous B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CBCL</z:e>) and 21 as B-cell <z:e sem="disease" ids="C0221269" disease_type="Disease or Syndrome" abbrv="">pseudolymphomas</z:e> (B-PSL) </plain></SENT>
<SENT sid="5" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CBCLs</z:e> included 15 follicular <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (FL), 6 marginal zone <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MZL</z:e>), and 11 diffuse large B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (LCL) </plain></SENT>
<SENT sid="6" pm="."><plain>The number of CD8-positive cytotoxic T cells was determined by computer-assisted morphometrical microscopy </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: No significant difference could be detected in the density of CD8-positive T cells in B-PSL (101/105 microm(2)), FL (110/105 microm(2)), and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MZL</z:e> (122/105 microm(2)) </plain></SENT>
<SENT sid="8" pm="."><plain>In contrast, the number of CD8-positive cells (55/105 microm(2)) in LCL was significantly lower (p&lt;0.01) compared to B-PSL, FL and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MZL</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: In summary the number of CD8-positive T cells in B-cell <z:hpo ids='HP_0005523'>lymphoproliferative disorders</z:hpo> differs in regard to <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> type and differentiation with lowest numbers in diffuse large B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>However, due to an overlap of the number of TILs, this parameter cannot be employed as a diagnostic parameter for individual cases </plain></SENT>
</text></document>